Brian Johnson, MD
MOHS-Micrographic Surgery · Norfolk, VANPI 1164495115
Payments from drug & device makers
Across 430 payments — averaging $4117.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$521K
- Sanofi US Services Inc.$491K
- Amgen$278K
- Janssen Research & Development, LLC$204K
- Eli Lilly$133K
- Mindera Corp$86K
- plus $57K from 22 others
Across 17 payments — averaging $596.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7K
- Sanofi US Services Inc.$3K
What the payments were for
- Travel & lodging$1,21024%
- Food & beverage$3,67274%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 157 | $520,531 |
| Sanofi US Services Inc. | 48 | $490,970 |
| Amgen | 14 | $278,248 |
| Janssen Research & Development, LLC | 33 | $204,195 |
| Eli Lilly | 2 | $133,173 |
| Mindera Corp | 3 | $86,210 |
| AbbVie(2 entities) | 85 | $46,018 |
| Sanofi | 2 | $9,456 |
| Johnson & Johnson | 22 | $588 |
| Genentech USA, Inc. | 12 | $212 |
| LEO Pharma Inc. | 7 | $162 |
| Bayer | 7 | $120 |
| Sun Pharmaceutical Industries Inc. | 5 | $94 |
| Novartis | 4 | $87 |
| Janssen Scientific Affairs, LLC | 2 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Lilly USA, LLC | 4 | $72 |
| Bristol Myers Squibb | 3 | $63 |
| Galderma Laboratories, L.p. | 3 | $50 |
| Kerecis Limited | 1 | $50 |
| Strata Skin Sciences, Inc. | 5 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,770,651 in reported general payments places this provider in the 95th percentile of 36 mohs-micrographic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 130 | $1,906 |
| Fluorouracil | 16 | $1,498 |
| Clobetasol Propionate | 21 | $1,208 |
| Triamcinolone Acetonide | 16 | $247 |
| Ibuprofen | 20 | $88 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $66 |
| Tramadol Hcl | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Norfolk
- Brian JohnsonNorfolk$34K
- James BotaNorfolk$9K
- Sherry MaraghAshburn$12K
- Kristin BibeeCharlottesville$11K
- Amir BajoghliMc Lean$9K
- Kenneth NealArlington$9K
- Matthew WallaceRichmond$4K
- Soonyou KwonVienna$4K
- Jeffrey ScottFairfax$3K
- Jason GivanLynchburg$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.